WASHINGTON, Sept. 21 -- In response to a federal agency request for information, the following public comment letter was submitted electronically to the regulations.gov site. September 14, 2026 Centers for Medicare & Medicaid Services (CMS) U.S. Department of Health and Human Services (HHS) Attention: CMS-1848-P P.O. Box 8013 Baltimore, MD 21244-8013 Re: Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies (CMS-1848-P) AbbVie appreciates more ST

WASHINGTON, Sept. 21 -- In response to a federal agency request for information, the following public comment letter was submitted electronically to the regulations.gov site. HEALTH DATA SAFE healthdatasafe.org Public comment on a request for information Submitted to: Administrator, Centers for Medicare & Medicaid Services U.S. Department of Health and Human Services CMS-2026-2377 Re: Current Procedural Terminology (CPT) Request for Information, Section II.H of the CY 2027 Physician Fee Schedule proposed rule CMS-1848-P. 91 FR 43842  more ST

WASHINGTON, Sept. 16 -- Judicial Watch issued the following news release: * * * September 16, 2026 Judicial Watch Uncovers Anti-Charlie Kirk Emails at Utah University Following His Assassination (Washington, DC) - Judicial Watch announced today that it obtained 133 pages of records from Utah Valley University (UVU) through a Utah Government Records Access and Management Act (GRAMA) request revealing sharply anti-Charlie Kirk messages from individuals identified as university faculty or instructors in the weeks following Kirk's assassination more PR

CHAPEL HILL, North Carolina, Sept. 16 -- The University of North Carolina Lineberger Comprehensive Cancer Center issued the following news: * * * UNC Researchers Awarded Two NIH R01 Grants to Advance Research on Obesity, Weight Loss Medications and Cancer Prevention/Interception September 16, 2026 Researchers at the University of North Carolina at Chapel Hill have been awarded two new National Institutes of Health (NIH) R01 grants totaling more than $7.1 million to investigate how incretin mimetics, including GLP-1 receptor agonists and rel more PR